Mar 2, 2026 04:34PM
Feb 27, 2026 08:00PM
Feb 25, 2026 06:38AM
Feb 23, 2026 04:05PM
Feb 18, 2026 05:31PM
Feb 12, 2026 07:41AM
Dec 19, 2025 07:45AM BioMarin to acquire Amicus Therapeutics for $4.8 billion
Dec 19, 2025 07:45AM
Oct 29, 2025 09:01AM
Oct 29, 2025 09:00AM
Oct 28, 2025 06:41AM
Oct 27, 2025 04:03PM
Sep 8, 2025 09:00AM
Sep 6, 2025 11:05AM BioMarin reports positive phase 3 trial results for adolescent PKU treatment
Sep 6, 2025 11:05AM
Aug 30, 2025 04:00PM
Aug 4, 2025 04:02PM
Jul 15, 2025 06:15AM
Jun 25, 2025 10:03AM
Jun 24, 2025 09:02AM
Jun 24, 2025 09:00AM BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 Congr
Jun 5, 2025 12:44PM
May 12, 2025 09:06AM
May 12, 2025 09:05AM
May 1, 2025 04:05PM
Apr 10, 2025 05:32AM
Apr 2, 2025 09:06AM
Apr 2, 2025 09:00AM BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria
Mar 20, 2025 09:00AM
Mar 11, 2025 07:05AM
Feb 19, 2025 04:05PM
Nov 30, 2024 04:00AM
Nov 16, 2024 10:45AM
Oct 29, 2024 04:03PM
Sep 18, 2024 08:00AM BioMarin to Present Data Underscoring Sustained Positive Impact of VOXZOGO® (vosoritide) on Health-Related Quality of Life, Growth and Maintenance of Bone Strength in Children with Achondroplasia at
Aug 5, 2024 04:03PM
Aug 5, 2024 04:01PM
Aug 5, 2024 04:01PM
Jul 24, 2024 04:05PM
Jun 17, 2024 08:30AM
Jun 7, 2024 09:00AM
Jun 7, 2024 09:00AM BioMarin Presents New Phase 3, Four-Year Data Underscoring Long-Term Safety and Efficacy of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2024 Co
May 4, 2024 04:00PM
Apr 24, 2024 04:03PM
Mar 12, 2024 08:30AM
Feb 22, 2024 04:03PM
Feb 6, 2024 08:30AM
Nov 28, 2023 08:32AM
Nov 28, 2023 08:30AM BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in Germany
Nov 1, 2023 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All